1-3 of 3
Selena A Rush, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Carfilzomib (CFZ) with or without Filanesib (FIL) in Patients with Advanced Multiple Myeloma (MM)

Jeffrey A Zonder, MD, Saad Usmani, Emma C. Scott, MD, Craig C. Hofmeister, MD, Nikoletta Lendvai, MDPhD, Jesus G. Berdeja, MD, Larry D. Anderson, Jr., MD PhD, Parameswaran Hari, MBBS, MD MRCP, Seema Singhal, MD, Gregory Orloff, MD, Michael Craig, MD, Jason Valent, MD, Wes Lee, Lowell Hart, J Hrom, Stephano Tarantolo, Edward Faber, DO, Gary J Schiller, MD, Jennifer Schreiber, BS, Colleen Oliver, MSc, Selena A Rush, BS, Brian Tunquist, Mieke Ptaszynski, Noopur S. Raje, MD
Journal: Blood
Blood (2015) 126 (23): 728.
https://doi.org/10.1182/blood.V126.23.728.728
Published: 2015
Journal Articles

A Phase 1 Study Of ARRY-520 With Bortezomib (BTZ) and Dexamethasone (dex) In Relapsed Or Refractory Multiple Myeloma (RRMM)

Ajai Chari, MD, Myo Htut, MD, Jeffrey Zonder, M.D., Joseph W. Fay, MD, Andrzej J Jakubowiak, MD, PhD, Beverly Harrison, Kenneth Lau, BA, Brandi Hilder, Ann Ptaszynski, Selena A Rush, BS, Jonathan L. Kaufman, MD, Steven Michael Burt
Journal: Blood
Blood (2013) 122 (21): 1938.
https://doi.org/10.1182/blood.V122.21.1938.1938
Published: 2013
Journal Articles

Prolonged Survival and Improved Response Rates With ARRY-520 In Relapsed/Refractory Multiple Myeloma (RRMM) Patients With Low α-1 Acid Glycoprotein (AAG) Levels: Results From a Phase 2 Study

Sagar Lonial, M.D., Jatin J. Shah, M.D., Jeffrey Zonder, M.D., William I. Bensinger, MD, Adam D. Cohen, MD, Jonathan L. Kaufman, MD, Ajay K. Nooka, MD, MPH, Donna M. Weber, M.D., Brandi Hilder, Selena A Rush, BS, Ann Ptaszynski, Duncan Walker, PhD, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 285.
https://doi.org/10.1182/blood.V122.21.285.285
Published: 2013